Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma
Stefano Scalera, Biagio Ricciuti, Marco Mazzotta, Nicola Calonaci, Joao V. Alessi, Laura Cipriani, G. Bon, B. Messina, Giuseppe Lamberti, Alessandro Di Federico, Federica Pecci, Salvatore Milite, Eriseld Krasniqi, Maddalena Barba, Patrizia Vici, Andrea Vecchione, Francesca De Nicola, Ludovica Ciuffreda, Frauke Goeman, Maurizio Fanciulli, Simonetta Buglioni, Edoardo Pescarmona, Bijaya Sharma, Kristen D. Felt, James Lindsay, Scott J. Rodig, Ruggero De Maria, Giulio Caravagna, Federico Cappuzzo, Gennaro Ciliberto, Mark M. Awad, Marcello Maugeri‐Saccà
Topics & Concepts
MedicineLoss of heterozygosityImmunotherapyAdenocarcinomaImmune systemInfiltration (HVAC)Lung cancerLungCancer researchAdenocarcinoma of the lungOncologyPathologyImmunologyInternal medicineGeneticsCancerAlleleGeneBiologyThermodynamicsPhysicsCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosisLung Cancer Treatments and Mutations